Sign up to watch this video
Free access to all Sound Bites content
Dr. Tara Graff reviews the efficacy of Pola-R-CHP in select LBCL subgroups (Video 2/3)
Published on: February 11, 2026
Medical Professional
POLARIX subgroups
Related Videos
Dr. Joshua Reuss discusses the design of the BEAMION Lung trial of zongertinib in HER2m NSCLC (Video 1/3)
Joshua Reuss, MD
Dr. Tara Graff reviews the efficacy of Pola-R-CHP in select LBCL subgroups (Video 2/3)
Tara Graff, MD
Dr. Tara Graff discusses the 5-year efficacy of Pola-R-CHP in LBCL (Video 1/3)
Tara Graff, MD
Dr. Eric Singhi describes differentiating safety aspects of cemiplimab in patients with aNSCLC (Video 3/3)
Eric Singhi , MD
Dr. Charu Aggarwal presents intracranial activity for datopotamab deruxtecan in pretreated mNSCLC (Video 3/3)
Charu Aggarwal, MD
Dr. Charu Aggarwal reviews safety highlights for datopotamab deruxtecan in pretreated mNSCLC (Video 2/3)
Charu Aggarwal, MD
IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America
© 2025 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.